FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Non GMO

  • Home
  •  | 
  • Tag Archives: "Non GMO"

Future Farm’s Commitment to Non-GMO Cannabis

Future Farm’s Commitment to Non-GMO Cannabis
Vancouver, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce its commitment to socially responsible, non-GMO cultivation of the cannabis plant. It plans to implement this commitment by deepening its relationship with Rahan Meristem Ltd., a world renown global agro-biotechnology company incorporated in the State of Israel with more than 250 employees in five locations and over 40 years of experience in plant propagation and breeding (“Rahan”).
Read more

Cannabis Industry Leader Zenabis Ltd. signs LOI with Hillsboro Corp Inc., maker of True Buch Kombucha

Cannabis Industry Leader Zenabis Ltd. signs LOI with Hillsboro Corp Inc., maker of True Buch Kombucha
VANCOUVER, Oct. 16, 2018 /CNW/ - On October 4, 2018, Bevo Agro Inc. (TSXV: BVO) ("Bevo") announced that it had signed an Arrangement Agreement dated October 4, 2018 with Sun Pharm Investments Ltd. ("Sun Pharm") for a reverse take-over of Bevo, and announced its intent to change its name to Zenabis Global Inc ("Zenabis"). Through Sun Pharm'ssubsidiary licensed producer Zenabis Ltd. ("Zenabis"), Zenabis Global Inc. will have nearly 3.5 million square feet of available production space.
Read more

American Pain Association President Selects Tree of Knowledge as CBD Supplier — CFN Media

American Pain Association President Selects Tree of Knowledge as CBD Supplier — CFN Media
Cannabidiol, or CBD, has been widely studied for its potential benefits in improving a wide range of medical conditions. While there are many different suppliers of CBD oils, tinctures, and other products, there are few that are trusted by medical professionals willing to prescribe it to their patients. Investors may want to take a closer look at these providers as potential opportunities in the space—particularly those that are already building distribution inroads.
Read more